Neurology Specific Literature Search   
 
[home][thesaurus]
    
Click Here to return To Results

 

Practice Parameter: Pharmacologic Treatment of Spasticity in Children and Adolescents with Cerebral Palsy (an Evidence-Based Review): Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society
Neurol 74:336-343, Delgado,M.R.,et al, 2010
See this aricle in Pubmed

Article Abstract
For localized/segmental spasticity that warrants treatment, botulinum toxin type A should be offered as an effective and generally safe treatment (Level A). There are insufficient data to support or refute the use of phenol, alcohol, or botulinum toxin type B (Level U). For generalized spasticity that warrants treatment, diazepam should be considered for short-term treatment (Level B), and tizanidine may be considered (Level C). There are insufficient data to support or refute use of dantrolene, oral baclofen, or continuous intrathecal baclofen (Level U).
 
Related Tags
(click to filter results - removes previous filter)

antispasticity drugs
botulinum toxin
cerebral palsy
children
efficacy
intrathecal antispasticity drugs
practice guidelines
review article
safety
spasticity
spasticity,treatment of
tizanidine
treatment of neurologic disorder
valium

Click Here to return To Results